April 26, 2022
Vanessa Yen to Speak at American Conference Institute’s 17th Annual Paragraph IV Conference
April 20, 2022
Regulation of Cell and Gene Therapies: An Overview
April 12, 2022
David Farber, Lisa Dwyer, Adam Solander to Speak at BioDesign Israel Program
March 30, 2022
Maximizing Contract and Treaty-Based Protections For Cross-Border Transactions in the Pharmaceutical Industry
March 21, 2022
31st Annual Health Law & Policy Forum
March 21, 2022
Ulf Grundmann to Speak at SMi’s 16th Parallel Tade Conference
March 17, 2022
Geneviève Michaux to Speak at Annual Conference on EU Law in the Pharmaceutical Sector 2022
March 16, 2022
Eva Temkin, Chris Markus to Speak at Food and Drug Law Institute’s Conference About Biological Products
February 24, 2022
Navigating the Future: Considerations Related to “Femtech” and Other Digital Health Tools
January 25, 2022
2021 Year in Review for Drug and Device Advertising and Promotion – Lessons Learned From FDA Enforcement Letters and Other Key Developments
December 15, 2021
Eva Temkin, Elaine Tseng to Speak at AFDLI Food and Drug Law Institute Conference
December 1, 2021
Ransomware for Healthcare Providers: What You Need To Know Right Now